Page 355 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

Giant Cell Arteritis 329

Cross-Sectional Screening of Fifty- Four Prospectively Followed Patients. Arthritis
Care Res., 2008; 59:422–430.
[64] Agard C, Barrier J, Dupas B et al. Aortic Involvement in Recent-Onset Giant Cell
(Temporal) Arteritis: A Case–Control Prospective Study Using Helical Aortic
Computed Tomodensitometric Scan. Arthritis Care Res., 2008; 59:670-676.
[65] Luqmani R. Large vessel vasculitides: update for the cardiologist. Curr. Opin. Cardiol.,
2012; 27:578-584.
[66] Evans JM, O?Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and
dissection in giant cell (temporal) arteritis: a population-based study. Ann. Intern. Med.,
1995; 122:502-507.
[67] Nuenninghoff DM, Hunder GG, Christianson TJ, et al. Incidence and predictors of
large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery
stenosis) in patients with giant cell arteritis: a population-based study over 50 years.
Arthritis Rheum., 2003; 48:3522–531.
[68] Espitia O, Néel A, Leux C, et al. Giant Cell Arteritis with or without Aortitis at
Diagnosis. A Retrospective study of 22 patients with longterm followup. J. Rheumatol.,
2012; 39:2157–2162.
[69] Gonzalez-Gay MA, Garcia-Porrua C, Pineiro A, et al. Aortic aneurysm and dissection
in patients with biopsy-proven giant cell arteritis from northwestern Spain: A
population-based study. Medicine, 2004; 83:335-341.
[70] Klein RG, Hunder GG, Stanson AW, et al. Large artery involvement in giant cell
(temporal) arteritis. Ann. Intern. Med., 1975; 83:806-812.
[71] Ray JG, Mamdani MM, Geerts WH. Giant cell arteritis and cardiovascular disease in
older adults. Heart, 2005; 91:324–328.
[72] Brack A, Martinez-Taboada V, Stanson A et al. Disease pattern in cranial and large-
vessel giant cell arteritis. Arthritis Rheum. 1999; 42:311-317.
[73] Assie C, Janvresse A, Plissonnier D, et al. Long-term follow-up of upper and lower
extremity vasculitis related to giant cell arteritis: a series of 36 patients. Medicine 2011;
90:40-51.
[74] Schmidt WA, Moll A, Seifert A, et al. Prognosis of large-vessel giant cell arteritis.
Rheumatology, 2008; 47:1406-1408.
[75] Ninet JP, Bachet P, Dumontet CM, et al. Subclavian and axillary involvement in
temporal arteritis and polymyalgia rheumatica. Am. J. Med., 1990; 88:13-20.
[76] Hunder GG, Bloch DA, Michel BA et al. The American College of Rheumatology 1990
criteria for the classification of giant cell arteritis. Arthritis Rheum., 1990; 33:1122-
1128.
[77] Niederkohr RD, Levin LA. Management of the patient with suspected temporal arteritis
a decision-analytic approach. Ophthalmology, 2005; 112:744 –756.
[78] Costello F, Zimmerman MB, Podhajsky PA et al. Role of thrombocytosis in diagnosis
of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic
optic neuropathy. Eur. J. Ophthalmol., 2004; 14:245–257.
[79] Kyle V, Wraight EP, Hazleman BL. Liver scan abnormalities in polymyalgia
rheumatica/giant cell arteritis. Clin. Rheumatol., 1991; 10:294–297.
[80] Laria A, Zoli A, Bocci M, et al. Systematic review of the literature and a case report
informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein.
Clin. Rheumatol., 2012; 31:1389-1393.

Complimentary Contributor Copy